INTRODUCTION
It is commonly assumed that because proteins share sequence and structural similarity and can be grouped hierarchically into families and superfamilies based on that similarity, their evolutionary history is plain [1−6] . For many years, protein engineers reasoned from this that it should be relatively easy to shift enzymes to new functions, but experience has forced them to rethink this. In the words of two prominent protein engineers: "many attempts at interchanging activities in mechanistically diverse superfamilies have since been attempted, but few successes have been realized." [7] The results of these projects present two challenges for the Darwinian explanation of protein origins. First, when functional conversions are found to be possible in the laboratory, they almost always require many mutations [8−12] , which would make them unfeasible as natural occurrences. Second, the conversions achieved in the laboratory are invariably very weak [7,10−15] . For example, studying a natural bacterial aspartate decarboxylase, Wilson and Kornberg [13] measured a K m of 80 μM for L-aspartate and a maximal reaction rate (V max ) of 5.3×10 3 moles of aspartate decarboxylated per minute per mole of active-site PLP (pyridoxal-5′-phosphate), corresponding to a k cat value of 88s -1 . The three amino acid substitutions that Graber et al. [10] describe as converting aspartate aminotransferase into an aspartate decarboxylase require seven nucleotide substitutions to achieve an activity that is some 100,000-fold lower, based on k cat /K m . Very weak activities like this must be amplified in order for them to have any selective effect [7,14−16] , which means they could easily confer a selective disadvantage in a natural
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setting when the metabolic cost of overexpression is taken into account [17, 18] .
While new enzyme chemistry has proven very difficult to obtain, shifting the substrate or reaction preference of an enzyme toward a minor activity it already possesses is much easier. Many studies have demonstrated, for example, that one or two mutations can make certain enzymes favor a previously minor substrate or reaction [6, 19, 20] , and the relative ease of these transitions has led to speculation that they may have been important for the origins of enzyme diversity. The favored idea is that ancient enzymes were promiscuous, catalyzing side reactions in addition to their beneficial primary reaction [1, 6, 15, 20] . With changing circumstances, some of these side reactions could have proven useful, which might have led to their protein catalysts being recruited to specialize in those functions. Duplication of the encoding gene is thought to have provided the genetic material for this process of evolutionary specialization to proceed without loss of the original function.
This idea of functional divergence from promiscuous ancestral enzymes, though possibly of some value, leaves the most fundamental aspects of the origins question unchanged. Whether ancient enzymes resembled modern ones closely or only loosely, the modern ones are both the things to be explained and the things we can observe. The importance of grounding evolutionary explanations in actual study of modern enzymes therefore remains as important now as ever. Yet the promiscuity hypothesis leaves the actual origin of genuinely new enzyme functions unexplained. In the end, then, functional conversion by mutation is still the only evolutionary explanation for those first appearances.
Because of this, we focus here on the feasibility of the classical recruitment scenario where enzymes adopt an entirely new function. The process begins when a gene duplication event provides a spare gene encoding a structurally sound protein that need not perform any function. It is expected that the cost of carrying this superfluous gene, including possible effects on the expression of neighboring genes, would be at least a mild selective disadvantage to the host cell, but the idea is that on rare occasions mutations may cause the spare gene to provide a useful new function before purifying selection takes its course. If the new benefit outweighs the cost, then the net effect would be a selective advantage.
This scenario has some difficulties, however. Recognizing that conversions to new enzyme functions seem to require multiple mutations and that evolutionary feasibility drops precipitously with each required change, several investigators have calculated how the expected waiting time for these events depends on the number of required mutations [21−25] . Using estimated rates of mutation and gene duplication, along with average sizes and generation times for the population of interest, these calculations provide an upper limit on the number of nucleotide changes that a recruitment scenario can assume. This limit is surprisingly low even for huge bacterial populations. Under the most realistic assumptions, where the duplicate gene reduces bacterial fitness measurably prior to functional conversion [17] , it appears that the new function must be produced with no more than two specific mutations [21, 25] .
It is important to ask whether new enzyme functions can really evolve within this tight constraint. To frame the question more precisely, we previously gave a precise description of what would qualify as a genuinely new evolved function [26] . The two conditions we described were: 1) that the pre-evolved enzyme should have no detectable activity with respect to the evolved function, and 2) that this evolved function should not be capable of representation by a generalized chemical reaction (i.e., one using R groups) that also describes the pre-evolved function. Certainly, no explanation of enzyme diversity can be considered complete unless it handles newness of this kind.
With that in mind, the key question to be addressed here is this:
Are enzymes readily converted to new functions by just one or two mutations in their encoding genes?
The importance of considering conversion by just one mutation is that the overexpression needed for a weak conversion to be beneficial would itself typically require upstream genetic modifications. For example, to the best of our knowledge, the only demonstrations of conversion to a genuinely new enzyme function by single nucleotide substitutions are the conversions of two members of the MLE 1 subgroup of the enolase superfamily to a third function within this subgroup, that of o-succinylbenzote synthase (OSBS) [27] .
2 But with activities measuring only 0.06% and 0.0004% of wild-type OSBS activity [27] , the converted enzymes must be substantially overproduced in order for them to substitute for the wild-type enzyme in vivo. Since every additional mutation needed for this overexpression increases evolutionary waiting times dramatically, it is unclear whether recruitment can explain the origin even of OSBS function. The idea of recruitment being a general explanation of functional diversity within enzyme families therefore needs critical evaluation.
Notice that we deliberately pose the above question in the present tense. We are asking whether the enzymes now present in life are as amenable to functional conversion as ancient enzymes must have been in order for evolution to work. If the answer to this is No, then the classical recruitment scenario does not work today. That realization would be of considerable importance, in that it would call for careful consideration of how processes that do not work today somehow did work long ago. In other words, it would reinforce the importance of grounding evolutionary explanations in observable science.
We previously chose a test case for experimental examination of this crucial question. Our study [26] focused on the most structurally similar pair of enzymes from the GABA-aminotransferase-like 3 (GAT) family in E. coli that have distinct catalytic functions. One of these was 8-amino-7-oxononanoate synthase, which we designated BioF 2 (the subscript indicating the functional dimeric form), and the other was 1 Muconate lactonizing enzyme. 2 Näsvall et al. [28] have reported spontaneous mutations that enable the HisA of Salmonella enterica to substitute for TrpF, which the wild-type HisA cannot do. Although this is an example of a genuine change of substrate, it is not a genuine conversion of function, according to our definition, because the TrpF and HisA functions are represented by the same generalized chemical reaction. 3 GABA is an abbreviation for gamma-aminobutyric acid.
2-amino-3-ketobutyrate CoA ligase, which we designated Kbl 2 . BioF 2 carries out the first dedicated step in biotin biosynthesis [29, 30] , whereas Kbl 2 is a non-essential enzyme involved in threonine metabolism [31] . The chemical conversions catalyzed by the two enzymes are similar, both being classified as α-oxoamine synthase reactions (Figure 1 ), but they are genuinely distinct in that they cannot be represented by a single generalized reaction.
The Kbl and BioF monomers are 34% identical in sequence over an alignment that nearly spans their entire lengths (381 aligned positions; BioF length = 384; Kbl length = 398). As would be expected from full-length sequence identity at that level, they have similar overall fold structures (Figure 2A , B, and C). In fact, the structural similarity is in this case unexpectedly striking, as seen by the matching identity and placement of side chains within the two active sites ( Figure 2D ). Figure 3 places the structural similarity of this enzyme pair within the broader context of structural similarities among members of the whole PLP-transferase superfamily to which the GAT family belongs. Nodes in this graph are labeled with PDB accession codes with edges connecting nearest structural neighbors, sized according to the structural distance metric we defined previously, δ s [26] . At 0.44, the structural distance between BioF and Kbl is seen to be within the range of distances separating functionally identical enzymes from different species, and much smaller than many of the nearest-neighbor distances between functionally distinct members of this superfamily.
Having on this basis identified Kbl 2 and BioF 2 as a suitable pair for study, we set out in our prior study to estimate how many mutations would be needed to convert Kbl 2 to perform the function of BioF 2 . Based on sequence and structural alignments of these two proteins, and drawing on alignments of other bacterial proteins with the same functions, we tried to identify a small subset of amino acid positions where changing the Kbl residue to match its BioF counterpart would have the best chance of causing functional conversion. In the end, we were unable to achieve conversion, even after simultaneously changing nearly all side chains in the Kbl 2 binding pocket to match those of BioF 2 [26] . Based on this result, we argued that the answer to the above question does indeed seem to be No.
Here, we extend that prior work by examining two conceivable ways in which this No might be incorrect. First, the complexity of the connection between enzyme sequences and functions makes it possible that the rational approach we used may have missed a conversion that can actually occur within the two-mutation limit. And second, it is possible that some member of the GAT family other than Kbl 2 , though perhaps less similar to BioF 2 , may nonetheless happen to be better suited to this conversion. That these two possibilities are conceivable does not imply that they are likely. Nevertheless, we are proceeding with their examination for the sake of thoroughness. To the extent that they can be ruled out, we will have strengthened our initial conclusion. The present study unfolds in three parts. In the first part, we complete our previous rational approach by examining individually those mutations that were previously examined only in groups. This should clarify the picture of the effects of single mutations that look as though they ought to be among the most important. In the second and third parts, we move from the rational approach to a random approach where large libraries of mutant genes are produced and tested. The second part focuses on single mutations and the third focuses on double mutations. Because random mutations enable the possibilities to be tested in an unbiased way, they should give a true picture of whether functional conversion is readily achievable in just one or two mutations.
RESULTS

Part 1: Completing the examination of rational single mutations
Correction of a previously reported single knock-out mutation. Among the amino acid positions we examined in the prior study were fifteen that show high conservation among bacterial BioF proteins but that differ from the amino acids in the E. coli Kbl protein [26] . After examining the effects of replacing these residues in BioF with their Kbl counterparts (referred to as BioF→Kbl substitutions), we reported that one such change, H152N, caused complete loss of BioF 2 function, resulting in biotin auxotrophy (i.e., Bio -phenotype). In the process of preparing for the present study, we discovered that the gene encoding this H152N variant of BioF had an additional mutation that we mistakenly overlooked. This mutation replaces serine at position 265 (adjacent to the PLP cofactor, as seen in Figure 4 ) with glycine. The complete loss of BioF 2 function we previously attributed to the single H152N substitution should therefore be attributed to the double substitution H152N + S265G. To find out whether either of these two substitutions might explain the inactivation alone, we constructed new plasmids carrying each mutation singly. After testing, we found that both of these plasmids confer the Bio + phenotype, enabling cells without a chromosomal bioF gene to grow normally on minimal medium without biotin. So, neither H152N nor S265G eliminates BioF 2 function singlehandedly.
Having previously found H152 to be completely conserved across a sampling of fifty microbial BioF sequences from the Concise Microbial Protein Database (CMPD) 4 , we examined the conservation of S265. Although less strongly conserved than H152, this serine is conserved in ninety-nine of the hundred gammaproteobacterial sequences that show greatest similarity to the E. coli sequence, the one exception being an asparagine Nodes show PDB entry names colored according to SCOP family assignments (http://scop.berkeley.edu/sunid=53417): green = aspartate aminotransferaselike; blue = cystathionine synthase-like; brown = pyridoxal-dependent decarboxylase; red = GABA aminotransferase-like; cyan = beta-eliminating lyases; gold = glycine dehydrogenase subunits; purple = ornithine decarboxylase major domain; black = SelA-like. Edge lengths and connectivity are based on structural data as described previously [26] , with dashed edges connecting enzymes having different chemistries, grey edges radiating from nodes with poorly characterized functions, and bold black edges connecting enzymes that perform identical functions in different species. The greyhighlighted edge in the upper left connects the BioF structure with the Kbl structure. Other aspects of geometry (e.g., layout and distances between unjoined nodes) are arbitrary. Adapted from Figure (see Supplement S1 5 ). Similarly, this position is semi-conserved (serine or threonine) among the alpha-and betaproteobacteria we examined (see Supplement S2 6 ). This pattern is consistent with our finding that positions 152 and 265 of BioF are both sensitive to substitution, though neither of the native amino acids at these positions is absolutely required for function.
Phenotypic analysis of rational single mutations. This correction raises the possibility that of the 250 residues by which Kbl differs from BioF, there may be none that are absolutely incompatible with BioF 2 function. That is, if substitutions in BioF that increase its resemblance to Kbl must be combined in order to eliminate the BioF 2 function, then there may be no "wrong" amino acids in Kbl with respect to that function. Converting Kbl 2 to work like BioF 2 may be more a matter of making several changes that are helpful to that end than correcting any side chains that preclude it. Our previous findings hinted at this possibility. We found three sets of substitutions that eliminate BioF 2 function. However, when we tested the constituent substitutions in one of these sets (designated group 3) we found that none of them eliminates function on its own [26] .
To see whether the other sets (group 1 and group 2) behave the same way, we constructed low-copy plasmids with mutant bioF genes encoding each of the single amino-acid substitutions. As shown in Table 1 , no single BioF→Kbl substitution from group 1 is inactivating. However, in group 2 the mutation F258R does completely eliminate BioF 2 function. Phe 258 is located near the enzyme surface, just underneath the aminoterminal arm of the opposite monomer ( side chain is solvent-exposed, which makes radical destabilization upon mutation to Arg seem unlikely. F258R may instead interfere with the amino terminal arm's positioning, perhaps affecting dimerization or conformational change when the active site is occupied. None of the other single substitutions in group 2 eliminate function, despite their closer proximity to the substrate binding pocket.
Position 258 shows strong conservation of phenylalanine among the hundred gammaproteobacterial BioF sequences (87%), with a few threonine residues, one alanine residue, and nine tyrosine residues at that position (see Supplement S1 5 ). However, when the pool of sequences is expanded to include members of firmicutes and betaproteobacteria, only 49% have phenylalanine at the corresponding position. In fact, eleven sequences from the more distantly related bacteria (<43% sequence identity) have arginine at this position (see Supplement S2 6 ). The genes encoding these Arg-containing versions of BioF are located near other genes annotated as biotin biosynthetic enzymes in their respective genomes, so their designation as bioF is almost certainly correct. Evidently, then, the disruption caused by F258R in E. coli BioF is a matter of context rather than any indispensible role for phenylalanine at this position.
In the end, then, all single BioF→Kbl substitutions we have tested to date have failed to eliminate BioF 2 function except for F258R, which appears to exert its effect in a context-dependent way. It therefore seems quite possible that none of the amino acids in Kbl are wholly incompatible with BioF function in all sequence contexts.
Part 2: Examination of random single mutations
Choosing candidates for recruitment to BioF 2 function. To test whether a GAT-family enzyme other than Kbl 2 might be a better candidate for conversion to the function of BioF 2 than Kbl 2 , we considered the various possibilities. 7 Table 2 lists all members of the GAT family from E. coli, along with their sequence and structural similarity (when known) to BioF [32] , and the variety of reactions they catalyze, as indicated by their EC numbers. The more promising candidates from other bacterial species are also included. Enzymes with known structures were compared to BioF using the structural distance metric δ s , and the calculated distances were used to construct a nearestneighbor tree ( Figure 5A ).
Of all these enzymes, BioF 2 groups most closely with Kbl 2 , 5-aminolevulinate synthase (ALAS), and serine palmitoyltransferase (SPT). These four enzymes have close structural and functional similarities, belonging to the α-oxoamine synthase 7 Classification systems for the PLP-dependent transferases are numerous and differ in the details, though the overall picture is consistent. We have chosen to use the classification system defined by the curated structural database SCOP [34] for the enzymes whose structures have been determined, but have also included those listed as paralogs of GabT by Ecocyc [35] whose structures have not yet been determined.
family [32] . As shown in Figure 1 , they all catalyze a Claisen condensation between an amino acid and acyl-CoA, and except for Kbl 2 this condensation reaction is coupled with a decarboxylation reaction [30−33, 37−39] . The similarity of these enzymes is further confirmed by sequence alignment of α-oxoamine synthase family enzymes from the Conserved Domain Database (CDD), 8 chosen for wide phylogenic representation. The alignment reveals that they share broadly similar amino acid sequences, interspersed with regions of dissimilar sequence ( Figure 6 ). Interestingly, of the three groups of amino acid positions we identified as candidates for change in our previous work, group 1 and group 2 fall within those dissimilar regions, these groups being in loops in or near the active site. In contrast, group 3 is part of the more conserved carboxy-terminus.
Of the ten non-BioF 2 E. coli enzymes listed in Table 2 , we excluded two from testing on the basis of their relatively 8 http://www.ncbi.nlm.nih.gov/Structure/cdd/cdd.shtml low similarity to BioF 2 (see Figure 5B ), these being serine hydroxymethyl transferase (PDB:1DFO) and phosphoserine aminotransferase (PDB:1BJO). Another (putrescine-inducible 4-aminobutyrate aminotransferase) was excluded because it is substantially similar to GABA-aminotransferase, the two having identical functions and 54% sequence identity. To the remaining seven candidates we added two from other species. ALAS from R. capsulatus (PDB:2BWN) was added because of its structural similarity to BioF ( Figure 5 ) [40] and because its chemistry is particularly close to that of BioF 2 ( Figure 1 ) [38] . BIKB from T. thermophilus was added to our list of candidates because it has been described as having both Kbl 2 and BioF 2 activities in vitro [36] . As such, it is the most promising example of a potential promiscuous enzyme with both of these functions. Neither of these enzymes is as similar in sequence to BioF as Kbl is (Figure 7) , but structural and functional considerations are equally important. The seven candidate genes from E. coli were obtained from the ASKA plasmid library [41] , which contains all E. coli open reading frames inserted into the inducible expression vector pCA24N [41] . Genes encoding the two enzymes not from E. coli, the hemA gene encoding ALAS from R. capsulatus and the bikb gene from T. thermophilus, were cloned into the same vector in our laboratory as described in Methods. After confirming all nine genes by sequencing, we used the plasmids to transform KeioΔbioF [42] , an E. coli strain that cannot grow without biotin (Bio -phenotype) because it lacks the bioF gene. After two weeks of incubation on minimal medium without biotin, none of the overexpressed genes were found to confer the Bio + phenotype. This confirms the prior finding of Patrick et al. [15] that no E. coli gene can substitute for bioF simply by overexpression, and it extends that result to the two non-E. coli genes hemA and bikb. The fact that cell growth requires only a tiny amount of biotin [43] combined with the fact that these genes were substantially overexpressed makes this is a highly sensitive test. We are therefore confident that none of these tested enzymes has any significant tendency to catalyze the BioF 2 reaction in vivo, despite the fact that one of them (BIKB) was described as having that activity in vitro [36] 9 . Searching for random single mutations that rescue. To see whether any of the nine candidate genes can be made to confer the Bio + phenotype with a single mutation, each was taken through a single round of random mutagenesis using error-prone PCR with conditions optimized to give about one mutation per gene. After inserting the resulting gene libraries into clean pCA24N vector, each library was transferred by electroporation into KeioΔbioF and plated to minimal medium without biotin (see Methods). Trays were incubated for two weeks at 37° C to test for rescue, with no colonies appearing (see Table 3 ).
By sequencing the gene inserts in ten to twenty pre-selection transformants from each of the nine library transformations, we determined the average number of nucleotide substitutions per kilobase (kb) for each library. Assuming uniform distributions, those mutation rates were used to estimate the number of genes produced with exactly one base change (see Methods). As shown in Table 3 , in all cases the library diversity exceeds the total number of possible single mutations (about 3,600) by at least a factor of ten. Oversampling to this extent assures that it is unlikely that any specific single mutation would have gone untested in these experiments. Consequently, the absence of rescue shows that none of the candidate genes can be made to confer the Bio + phenotype with one point mutation. To verify that specific single mutations can be recovered from libraries of mutant genes prepared by our method, we made two variants of the bioF plasmid where translation is terminated 9 Because Kubota et al. [36] assayed both activities by detecting release of their common byproduct CoA-SH (see Figure 1) instead of detecting the products of biological significance, it is possible that their conclusion that both activities are present in vitro may be in error. Table 2 that we considered to be too structurally distant, and green indicating enzymes from other species (not included in Table  2 ). 1VEF and 2CFB are taken to be indicative of the structures of the corresponding E. coli enzymes, although they are from other bacterial species. A) Nearest neighbor structural distance graph. Edges between nodes are proportional to the structural distance between that pair. The arrangement is otherwise arbitrary. Where neighbors share the same general reaction, the edges between them are solid. Where their chemistry differs the edges are dashed lines. B) Radial lines proportional to each enzyme's structural distance from BioF (1DJ9) were drawn with BioF at the center. The circle drawn at 1.86 units shows our chosen distance cut-off for this study. prematurely by TAA stop codons. Both of these TAA codons were constructed by altering a single DNA base, one in the codon for K236, and in the other in the codon for Q257. After verifying that KeioΔbioF cells carrying either of these mutant plasmids are unable to grow on minimal medium without added biotin, we took the two genes through one round of random mutagenesis using the same protocol as before. This time about one in a thousand transformants formed colonies on biotin-free medium for each of the two libraries. The recovery of these revertants confirms that our libraries have good coverage of single-base substitutions. 
Part 3: Examination of random double mutations
As discussed in the introduction, it is conceivable that the rational approach we used previously [26] to identify the most promising amino-acid substitutions in Kbl 2 might have missed substitutions that actually work. From the above result, we can now be confident that we did not miss any amino-acid substitutions that can be achieved with a single DNA base change, because all of these should have been present in our library of mutant kbl genes. Moreover, it is now clear that the difficulty of conversion to BioF 2 function is not at all peculiar to Kbl 2 , as this conversion is now seen to require more than a single mutation from eight other seemingly plausible starting points.
To see whether two mutations might succeed where one did not, we chose two of our nine candidate genes for more extensive mutational analysis (knowing that the amount of work would make it impractical to examine all nine). Among E. coli genes, Kbl 2 is still the favored candidate for conversion to BioF 2 function for all the reasons that we first identified it as such. In addition to Kbl 2 , we decided to examine double mutations in BIKB because its putative promiscuous catalysis of both the Kbl 2 and the BioF 2 reactions in vitro [36] suggests that it might be within two mutations of in vivo conversion.
Having chosen these two, we took the kbl and bikb genes through extensive additional random mutagenesis, this time under conditions optimized to produce two mutations per gene. By performing five separate error-prone PCR reactions on kbl, the products of which were used in thirteen electroporations of KeioΔbioF, we were able to screen a library of forty million transformants. Sequence analysis of 101 genes from the pre-selection library revealed that about 20% (20 of 101) had two base substitutions, which means our library contains about 7.9 million doubly mutated genes. This corresponds to about 71% coverage of the 6.4 million possible double mutants, taking repeats into account. None of these transformants were able to grow on minimal medium without biotin.
Similarly, for BIKB we screened a library of 48 million randomly mutated plasmids for their ability to replace the missing BioF 2 activity in KeioΔbioF. Sequence analysis performed on 27 clones from the naïve library showed an average base substitution rate of about 1.1 per gene and an insertion/deletion rate of about 0.18 per gene. Using these rates, we estimate the throughput of double mutants without insertions or deletions to be 16%, which means that 7.7 million double mutants were examined, corresponding to 70% coverage of the possibilities with different functions, if more than a tiny fraction of these are important for making those functions different, then it may be effectively impossible for undirected mutations to stumble upon the right combinations for functional conversions.
Furthermore, careful inspection of the full biological context in which recruitment would have to occur turns up several other similarly weighty concerns [45] . For example, gene expression carries a measurable metabolic cost in bacterial populations, and natural selection has a proven tendency to curtail this cost by favoring mutations that halt expression of useless genes [17, 18] . Combined with the fact that reports of successful functional conversions typically depend upon overexpression to compensate for very weak activities, this raises serious questions about the relevance of these success stories to actual evolutionary processes. If overexpression is needed for a weak new function to have a beneficial effect, then the rarity of semi-stable gene duplicates that might initiate recruitment is compounded by the rarity of mutations that cause overexpression, over and above the rarity of mutations needed for functional conversion. Moreover, in order for maladaptive intermediates to be avoided, these mutations must occur in the right order, with conversion preceding overexpression.
The present study has added to our previous examination of these problems in several respects. We have shown, based on sequence alignment of α-oxoamine synthases (a subset of the GAT family), that our previous use of rational design did indeed target regions of Kbl 2 that are likely to be functionally (see Methods) . No conversion to the Bio + phenotype was obtained after 2 weeks of incubation at 37°C, this despite BIKB's putative functional promiscuity in vitro (see footnote 9 for a possible explanation).
DISCUSSION
The greatest challenge facing evolutionary accounts of enzyme origins is explaining how enzymes with new fold structures first appeared. Having made the case that this challenge is insurmountable in Darwinian terms [44] we turned our attention several years ago to the more modest challenge of explaining how enzymes that existed long ago might have been coaxed into putting their structures to new uses. Certainly there is no shortage of modern enzymes that use similar structures to perform different functions, and at first glance this may seem to fit the evolutionary account of enzyme origins.
However, because the point of studying protein origins is to explain how the many different functions arose, a successful explanation of enzyme diversity will have to focus more on the differences than on the similarities. The fact that subtle structural differences among the members of enzyme families cause profound functional differences might suggest that these functional differences are easily achieved, but the accompanying sequence differences, which are substantial, could equally support the opposite conclusion. That is, of the many amino acid differences (often hundreds) that distinguish any two enzymes significant. Furthermore we have now shown that the lack of a simple evolutionary transition to BioF 2 function is not at all unique to our initial choice of Kbl 2 as the starting point. Single mutations cannot convert any of eight other members of the GAT family to that function, despite the fact that all of these enzymes are regarded as close evolutionary relatives.
Finally, we have demonstrated that converting either Kbl 2 or BIKB to perform the function BioF 2 with two DNA base substitutions is at least mildly unlikely, in that neither conversion was found after examining over two thirds of the possibilities. Of course, many possibilities remain unexamined. Although it is certainly possible for a working combination to be among those unchecked possibilities, we think it is more informative at this point to ask whether the available evidence as a whole really supports the idea that evolutionary recruitment is the cause of functional diversity in enzyme families.
To that end, we return to our initial question, to which we give the same answer as before with greater evidential weight: No, enzymes are not readily converted to new functions by just one or two mutations in their encoding genes. All things considered, we should still expect that Kbl 2 and BIKB are among the best starting points for evolutionary conversion to the function of BioF 2 , and therefore that successful conversion from any good starting point would probably require no fewer than three changes to the coding region of the starting gene. Nevertheless, if we take two changes to be an open possibility, we should expect that any new activity achieved with so few changes will have to be amplified by overexpression. This adds a third change to the list of requirements, namely a change to the upstream region of the starting gene that elevates expression. Preceding these three changes is the initial duplication event, the change that sets the stage for recruitment.
Equation 10 of the population genetics analysis by Axe [25] tells us how long it would take for all of these necessary changes to come together to produce a successful evolutionary adaptation by the classical recruitment mechanism. Using the parameter values listed in Table 4 , we estimate that this would happen about once in 10 15 years. This timescale is multiplied a million-fold if three changes to the coding region are required, as seems probable in light of our inability to find conversion with two changes. Either way, the classical recruitment scenario is clearly problematic as an explanation of the origin of the BioF 2 function.
As tempting as it is to think this problem can be solved by adjusting the numbers that go into the calculation, the reality is that every adjustment that helps in one respect hurts in another. For example, an elevated mutation rate helps the situation by increasing the number of cells carrying precursors to the converted gene, but it simultaneously hurts by decreasing overall fitness through mutation load. The finding of Drake and coworkers that bacterial mutation rates tend to hover at about one mutation per 300 cells [48] is consistent with there being a selective disadvantage for sustained rates much higher than this. Indeed, even under conditions where elevated mutation rates enhance adaptation, there is a tendency for lower rates to be restored in the long run [50] . In E. coli, with a genome size of about 5×10 6 , a mutation rate of 10 -7 per nucleotide site per cell would cause about half of newly divided cells to carry a new mutation, which would certainly entail a fitness cost. Small pockets of a global bacterial population can easily sustain rates that high for short periods, but these subpopulations are continually replaced by the wild-type, which is of higher fitness when averaged over the conditions experienced by the entire population. To put this in perspective, if it were possible for this higher mutation rate to be sustained throughout a global population, then we calculate the waiting time for conversion to be about a billion years. Since that is definitely a long term, it only underscores the need to use a realistic long-term global average mutation rate rather than an exceptional one.
The possibility that other evolutionary scenarios, such as divergence from promiscuous ancestral enzymes, could perform better cannot be ruled out by this work. It is also conceivable that the function of BioF 2 is exceptionally hard to achieve 10 and that successful conversion would therefore require a particularly favorable starting point, perhaps with much higher sequence identity to BioF. But it is one thing to ask what is needed for conversions to work in the lab and another to ask whether we should expect similar conversions to have happened naturally. The problem for evolutionary explanations is that the very special circumstances needed to achieve even weak conversions in the lab translate into highly unrealistic evolutionary scenarios. If the promiscuity hypothesis seems to avoid this critique, it is not because the circumstances it assumes are any less special but only because they are much more hypothetical. In the end, then, when all laboratory experience with enzyme conversion is considered collectively in this light, it seems quite clear both that the classical recruitment explanation of enzyme diversity is 10 More probably, the function of OSBS (described in the Introduction) is exceptionally easy to achieve. As far as we know, this is the only enzyme activity shown to be acquired by single nucleotide substitutions in genes that encode enzymes with genuinely different functions and no prior OSBS function [27] . * Based on the expected total mutation rate for bacteria with a genome size of 10 6 base pairs, as found by Drake et al. [48] . † Based on data for pyrD in Salmonella enterica as reported by Reams et al. [49] .
severely undermined and that there is no credible evolutionary alternative.
Toward a correct interpretation of structural similarity
The claim that enzymes are related by descent is interesting only if those enzymes have significant differences in addition to their similarities. For this reason the claim that gene recruitment explains not only the functional diversity of the GAT family but also that of the greater PLP-transferase superfamily is indeed interesting. However, when we examine enzymes within this superfamily where the differences are as small as they can be without functional overlap, we find functional transitions to be evolutionarily implausible.
One way around this problem would be to restrict claims of recruitment to cases of even tighter similarity, where the functions do overlap. But this leaves all the more interesting transitions unexplained, which means it does little to account for the whole picture of enzyme diversity. The proposal that functional overlap was much more common in the remote past than it is now is at least an acknowledgement of the problem, but again, unless that idea finds much more evidential support that it has so far, it ought to be viewed with skepticism.
Although there is as yet no satisfactory theory of biology to take the place of Darwinism, we believe the time has come for serious pursuit of such a theory. To quote one of our previous papers [45] :
The insights we gain from the critique of neo-Darwinism can and should inform the construction of a new theory to take its place. That is, in pinpointing the key problems with the old theory we are identifying crucial respects in which its replacement must differ from it. We ourselves have become convinced that intelligent causation is essential as a starting point for any successful theory of biological innovation. If this is so, what is needed now is an elaboration of the general principles by which living things have been designed.
To that end, one of our inferred principles of design is this [45] :
The substantial reworking of a homologous structure needed to give it a genuinely new function is more suggestive of reapplication of a concept than adjustment of a physical thing.
And another is this [45] :
The implementation of innovation is nearly the opposite of ordinary physical causation. It is the topdown arrangement of matter in such a way that the resulting bottom-up behavior of that matter serves the intended purpose of the innovator.
Taking these two ideas together, it may be that our prior attempts to convert Kbl 2 to perform the function of BioF 2 failed not because we made the wrong alterations but rather because it is misguided even to think of this as an exercise in alteration. Perhaps we should think of this more in the way we think about writing. Sentences that convey different ideas may have similar structures, but when we write a sentence we start with the idea, not the sentence structure. We never take a sentence that conveys some other idea and ask which letters can be changed to make it better suited for our present purpose. The fact that different ideas end up being conveyed with sentences of similar structure, then, has nothing to do with recycling of sentences and everything to do with the suitability of certain forms for certain functions.
Might this be the right perspective from which to view Kbl 2 and BioF 2 ? They use similar structures not because they are both adjusted versions of some older enzyme, but instead because the purposes they serve happen to call for similar structures. As we found in this work, it is not that Kbl has amino acid residues that are incompatible with the function of BioF 2 , but rather that Kbl 2 is comprehensively suited to one function, while BioF 2 is comprehensively suited to another. To us this change of perspective has the feel of a turn in the right direction. It does not in itself take us very far, perhaps, but having made the turn, forward progress may become much more likely.
METHODS
Media and solutions
Cultures for plasmid preparation were grown in Terrific Broth (TB) with 20 μg/ml chloramphenicol (TBC20) (Sigma). Standard solid culture was on LB agar (Fluka) for strains without plasmids. All plasmid-bearing strains were maintained on LB with 20 μg/ml chloramphenicol (LBC20). Minimal medium was either Minimal Davis Broth or Davis Minimal Agar from Fluka (abbreviated MDM or MDMC with chloramphenicol) with supplements as follows. Glucose and methionine were added to final concentrations of 0.5% and 0.2%, respectively, and salts to 1× concentration (the 100× stock containing the following in 100 ml water: 10g NH 4 For phenotype testing of plasmids, biotin (Fluka) was added just before pouring to a final concentration of 20 ng/ml (MDMCB) or streptavidin (Sigma) to a final concentration of 100 ng/ml (MDMCSA). For screening mutant libraries, isopropyl-β-Dthio-galactopyranoside (IPTG) (Affymetrix) was spread (final concentration 1 mM) on the day of plating onto plates or trays to induce overexpression of the targeted gene. Plasmid preparation, gel purification, and PCR purification kits were from Qiagen.
Strains and plasmids
The strains used in this work (all E. coli) are listed in Table  5 . Strain AG1, from the National BioResource Project (NIG, Japan): E. coli (abbreviated NRBP (NIG, Japan): E. coli), was used for cloning hemA (the gene encoding ALAS) and bikb (the gene encoding BIKB) into plasmid pCA24N. The in-frame single-gene knockout strain KeioΔbioF [42] (obtained from NBRP) was used for phenotype-testing mutant libraries (see Part 2 and Part 3 of Results), while 1D3ΔbioF [26] was used for testing single mutations to bioF for their effects (see Part 1 of Results). ASKA plasmids carrying E. coli genes bioF, kbl, bioA, hemL, gabT, astC, argD, and ygjG and the parent plasmid pCA24N were obtained from the National BioResource Project of Japan (NBRP-E. coli at NIG). Their construction is described by Kitagawa et al. [41] . We used plasmid pCA24N for cloning hemA and bikb, as described below. Plasmid pKBF2 [26] was our starting point for making individual mutations to bioF (Part 1 of Results).
Site-directed mutagenesis of bioF
Plasmids carrying specific mutations to the bioF gene (see Part 1 of Results) were generated by inverse PCR of pKBF2 with primers designed to introduce the desired mutations. Ligated PCR products were used to transform strain NEB 5-alpha to allow DNA methylation without host restriction. Transformed colonies on LBC20 were streaked and their plasmids purified and sequenced to confirm genotype. Plasmids were then used to transform strain 1D3. These transformants were pre-cultured for two days in MDMCB broth to adapt the cells to minimal culture. Phenotypes were tested as described. Briefly, 1 ml of pre-adapted cell culture was washed in ice-cold phosphate-buffered saline (PBS), and spread onto LBC20 plates for cell counts, onto MDMCB plates as a check of efficiency of growth on minimal medium with biotin, and onto MDMCSA plates to assess growth on minimal medium without biotin. Control strains 1D3:pKBF2 (Bio + ) and 1D3:pH152N/S265G (Bio -) were preconditioned and plated in parallel with every experimental set. All were incubated at 30° C and checked at 42 hours for growth.
Construction of ALAS and BIKB plasmids
To insert the genes encoding ALAS and BIKB into pCA24N, we followed the protocol used to generate the ASKA library [42] . Briefly, genomic DNA from R. capsulatus, and T. thermophilus (both from ATCC) was amplified using gene-specific primers with short N-terminal tags, as described [41] . After purification, the amplified genes were inserted by blunt end ligation into plasmid pCA24N that had been pre-digested with StuI and gel purified. The N-and C-terminal tags on the primers were designed to create unique SfiI sites at the ligation junctions, but only when insertion is in the proper orientation. All plasmid sequences were verified before experiments were performed.
Preparation of randomly mutagenized gene libraries
For experiments where our target was one random mutation per gene (Part 2 of Results), the desired template was amplified from the appropriate plasmid using Mutazyme II (Stratagene) and flanking primers ASKM-F and ASKM-R (see Figure 8) . Conditions for amplification were as specified in the Mutazyme II kit (Stratagene). We determined experimentally that starting with 700 ng of template and amplifying for 22 cycles produced about one base substitution per kilobase of template. Following amplification, mutagenized PCR products were column purified (Qiagen), digested with DpnI (NEB), column purified again, digested with SfiI (NEB), and then column purified one last time. The product was dried completely and resuspended in water. The vector for cloning the SfiI-digested PCR products was prepared by SfiI digestion of the ASKA plasmid that carries gene mrdA (which is large enough to allow clean separation of the vector and insert) followed by gel purification of the linearized vector with a Qiagen kit. This linearized vector has two different SfiI ends that match those of the mutagenized, SfiI-digested PCR products above, guaranteeing insertion in the right direction. Vector and inserts were ligated with Quick Ligase (NEB) and column purified, eluting with water for electroporation.
For experiments where our target was two mutations per gene (Part 3 of Results), the Mutazyme II PCR amplification time was increased to 28 cycles. For the bikb library we performed five additional amplification cycles after mutagenesis by adding Taq polymerase (NEB) to the reaction mix. Both bikb and kbl libraries were then prepared by DpnI and SfiI digestion as described above. Finally, each batch of kbl mutant library was gel purified to remove extraneous priming products after the SfiI digest. For bikb library batches we used column purification instead to increase the yield. Purified, digested library DNA was ligated into SfiI-digested pCA24N using T4 DNA ligase (NEB) as before.
Library electroporation
Part 2 of our work required fewer than 100,000 transformants per starting gene to cover all single base changes. The ligation product was therefore directly electroporated into 50 μl electrocompetent E. coli KeioΔbioF cells, using a BioRad Gene Pulser II with settings of 25 μF, 200 Ω, and 2.5 kV and a 2 mm gap cuvette. Immediately after pulsing, cells were suspended in 975 μl SOC medium and incubated at 37° C, 250 rpm for 90 min, then spread onto a 245×245 mm LBC20 tray (Becton Dickenson) and incubated overnight at 37° C.
To reach our target of forty million transformants for each of the double-mutant libraries prepared in Part 3 of our work, we pooled the products of five rounds of PCR mutagenesis and used the pooled DNA for repeated electroporations (13 for Kbl and 25 for BIKB). In these two cases, the DNA was first used to transform NEB 10-beta electrocompetent cells to increase the yield of initial transformants. Plasmid DNA prepared from these combined transformants was then used to transform electrocompetent E. coli KeioΔbioF, spreading onto LBC20 trays as before.
Library screening
Transformed KeioΔbioF cells were washed from the trays and pre-cultured for two days (for single mutations; Part 2) or one day (double mutations; Part 3) in MDMCB broth at 37° C to adapt the cells to minimal medium. One ml of pre-adapted cell culture was washed four times in ice-cold PBS. A small portion of the resulting cell suspension was diluted one million fold and spread on LBC20, MDMCB, and MDMCSA plates for cell counts and positive and negative controls (see below). The remaining undiluted cells (typically numbering in the millions) were spread onto MDMCSA + IPTG agar trays, and incubated for two weeks at 37° C.
Because bacterial cells require only trace quantities of biotin for growth, screening for biotin autotrophy (phenotype Bio + ) requires careful controls. For each test, we used single batches of freshly prepared medium and plated both an appropriate positive control strain (either KeioΔbioF:pbioF-ASKA or 1D3:pKBF2) and negative control strain (either KeioΔbioF:pbioA-ASKA or 1D3:pH122N S265G) in parallel with experimental strains.
Sequencing and analysis of library samples
For Part 3 of our work (where the focus was random double mutations), individual colonies were transferred from the naïve (i.e., pre-selection) library to fresh plates, and sent as colonies for sequencing of the ASKA insert. For Part 2 (where the focus was random single mutations), sequencing was performed on from ten to twenty samples, either bacterial colonies from the naïve library (as above) or PCR-amplified mutant genes. All sequencing was done by Genewiz, Seattle, WA.
For the double-mutant analysis of kbl (Part 3), a total of 101 naïve colonies were sent for sequence analysis. With twenty confirmed double-mutant kbl genes among that set, this fraction (20/101) was deemed to be a reasonably accurate measure of the proportion of double mutants within the naïve library. The fractional coverage of the 6.4 million possibilities was calculated from this by assuming a uniform distribution of possibilities within the library.
The number of mutant genes sequenced was substantially lower (in the range of ten to twenty) for all other library experiments (i.e., the nine experiments in Part 2 and the experiment with the BIKB gene in Part 3). In these cases we used the rate of insertion/deletion mutations per kilobase sequenced (fifth column of Table 3 ) to estimate the fraction of each library that lacked insertions or deletions, and the rate of nucleotide substitutions per kilobase sequenced (fourth column of Table 3 ) to estimate the fraction of each library with the desired number of mutations, assuming the number of mutations per gene to follow a Poisson distribution.
